Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02430337 · ClinicalTrials.gov registry record · NA

A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare

A NA study of Child Maltreatment and Implementation, sponsored by Georgia State University.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT02430337: Completed NA study of Child Maltreatment and Implementation, sponsored by Georgia State University.

NCT02430337 is a NA study of Child Maltreatment and Implementation that has completed, run by Georgia State University. The registered enrollment target is 31 participants, below the 2,456-participant average among 17 other Child Maltreatment trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02430337, a NA study of Child Maltreatment and Implementation, has completed, sponsored by Georgia State University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

In this study, a computer-assisted adaptation of SafeCare, an evidence-based home visiting program, will be developed and tested in child welfare. This approach will assist home visitors with the delivery of SafeCare to families, with the goal of improving provider fidelity and implementation success. In the computer-assisted SafeCare sessions, a portion of the session will be delivered on a tablet computer that the home visitor brings to the family's home. The computer software will deliver the educational piece, or explain a piece of each session, along with modeling videos of the skills. The home visitor will follow up with the practice and feedback portions of the session. A randomized feasibility trial will be conducted to test the technology-based approach against the standard SafeCare implementation approach in terms of feasibility of implementation, provider job demands, and resources, as well as client outcomes such as skill acquisition and mental health.

Primary Outcome

The investigators examined provider qualitative feedback to count the number of participants reporting that the Technology-Assisted SafeCare was acceptable and feasible. Interview data was transcribed and summarized to examine themes reported by the Tech-Assisted SafeCare providers' at the time of their exit interview (approximately six months after the baseline assessment).

Interventions

  • BEHAVIORAL Technology-Assisted SafeCare
  • BEHAVIORAL SafeCare

Study Locations (1)

Georgia

  • Georgia State University, School of Public Health, National SafeCare Training & Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2013-04
Est. Completion 2016-12
Phase NA
Georgia State University

45 total trials

What the finished NCT02430337 record still lists

NCT02430337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 2,456-participant average among 17 other Child Maltreatment trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Child Maltreatment appearing as the primary indexed condition, and to 2 interventions - of which Technology-Assisted SafeCare is the first listed.

NCT02430337 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT02430337 about?

NCT02430337 is a clinical study titled "A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare". In this study, a computer-assisted adaptation of SafeCare, an evidence-based home visiting program, will be developed and tested in child welfare. This approach will assist home visitors with the delivery of SafeCare to families, with the goal of improving provider fidelity and implementation succes...

What is the current status of trial NCT02430337?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2013-04. Estimated completion is 2016-12.

What conditions does trial NCT02430337 study?

This clinical trial studies the following conditions: Child Maltreatment, Implementation, Technology.

What interventions are being tested in trial NCT02430337?

The interventions under investigation include: Technology-Assisted SafeCare (BEHAVIORAL), SafeCare (BEHAVIORAL).

Who is sponsoring clinical trial NCT02430337?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02430337 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Maltreatment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02430337's enrollment target sits among peer trials

31 18th of 17 the lowest of 17 other Child Maltreatment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Child Maltreatment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02430337, the US trial registry maintained by the National Library of Medicine. NCT02430337 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.